Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/12492
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumarasena, R.S.
dc.contributor.authorNiriella, M.A.
dc.contributor.authorRanawaka, C.K.
dc.contributor.authorMiththinda, J.K.N.D.
dc.contributor.authorde Silva, A.P.
dc.contributor.authorDassanayake, A.S.
dc.contributor.authorde Silva, H.J.
dc.date.accessioned2016-04-04T07:04:48Z
dc.date.available2016-04-04T07:04:48Z
dc.date.issued2016
dc.identifier.citationThe Ceylon Medical Journal.2016; 61(1):35-36en_US
dc.identifier.issn0009-0875 (Print)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/12492
dc.description.abstractIn a retrospective study involving 240 patients with dengue infection, we attempted to identify early predictors of acute liver failure (ALF). Sixteen out of 41 patients with serum AST more than 1000 IU/ml developed ALF compared to none with serum AST less than 1000 IU/ml. Among patients with serum AST more than 1000 IU/ml, presence of two of the three following phenomena, within the first 5 days of illness: elevated serum bilirubin, elevated alkaline phosphatise or persistent nausea and vomiting, predicted development of ALF (93.8% sensitivity, 98.7% specificity, 83.3% positive predictive and 99% negative predictive value). The presence of elevated serum bilirubin, alkaline phosphatase and persistent nausea and vomiting in patients with very high serum AST during the early phase of dengue infection should alert the physician of impending ALF.en_US
dc.language.isoen_USen_US
dc.publisherSri Lanka Medical Associationen_US
dc.subjectLiver failureen_US
dc.titlePredicting acute liver failure in dengue infectionen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
8260-29059-2-PB.pdf46.91 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.